May/June 2024

Featured Article

From the Field

Shifting the Paradigm: The Impact of AI at the Point of Care in Cancer Treatment

06/03/2024

Stephen Speicher, MD, MS

Will Shapiro

Taylor Dias-Foundas

This report explores the transformative impact of artificial intelligence (AI) in health care, emphasizing its potential paradigm shift and current deployment in oncology.

This report explores the...

06/03/2024

Journal of Clinical Pathways

Research Reports

PSA Outcomes and Clinical Surveillance Among Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With a Next-Generation Androgen Receptor Inhibitor in Urology Practices With or Without In-Office Dispensing

06/03/2024

Sabree C. Burbage, PharmD

Dexter Waters, MSPH

Carmine Rossi, PhD

Frederic Kinkead, MA

Erik Muser, PharmD

Lorie Ellis, PhD

Patrick Lefebvre, MA

Dominic Pilon, MA

This study describes prostate-specific antigen (PSA) outcomes and clinical surveillance patterns among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) receiving next-generation androgen receptor inhibitors (ARIs)...

This study describes...

06/03/2024

Journal of Clinical Pathways

From the Field

Bringing Value to Health Care

06/03/2024

Andrew Pecora, MD

Lili Brillstein, MPH

Maher Albitar, MD

Nasim Asfar, MD, MBA, SFHM

Joel Brill, MD

Jeffrey R. Curtis, MD, MS, MPH

Andrew von Eschenbach, MD

Deborah Goss, MD

Andre Goy, MD

Max Holfert

Andrew Ip, MD, MS

Allen Karp

Mark Lutes

Steven Madreperla, MD, PhD

Patrick A. Roth, MD

Miruna Sasu

Robert Shelley

Robin L. Smith, MD, MBA

Nina Tandon, PhD, MBA

Dan Varga, MD

Richard Winters, MD

This paper provides insights and perspective from each constituent involved in shaping health care payment and delivery throughout the US.

This paper provides insights and...

06/03/2024

Journal of Clinical Pathways

Column

Transformative Employer Trends

Pathways, Affordability, and Utilization for Precision Therapies

06/03/2024

F. Randy Vogenberg, PhD, FASHP

Jeffrey Warren, MPA

Alasdair Roe, ACII

This column discusses how there is a stakeholder disconnect in precision medicine, leaving employers and other commercial plans or administrators seeking solutions as they face emerging risks from precision therapies.

This column discusses how there...

06/03/2024

Journal of Clinical Pathways

MAI Mindset

December 2023 Pathways Impact Study Part 3: Importance of “on-Pathway” Status for Treatment Selection

06/03/2024

Lee Blansett, MBA

This entry of our MAI Mindset column summarizes the third part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

This entry of our MAI Mindset...

06/03/2024

Journal of Clinical Pathways

Editor's Page

Perspectives on Fixing a Disjointed Health Care System

06/03/2024

Winston Wong, PharmD, Editor-in-Chief

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including perspectives from stakeholders on the disjointed health care system in the US and how clinical pathways can help fix it.

Editor-in-Chief Winston Wong,...

06/03/2024

Journal of Clinical Pathways

EXPERT ROUNDTABLE

Oncology Care Pathways: Perspectives on Strategies and Best Practices

06/03/2024

Gordon Kuntz, Kuntz Consulting, LLC

Jeremy Drainville

James Hamrick, MD, MPH

Larry Shulman, MD

Bryan Loy, MD

In this roundtable, part of a content partnership between Journal of Clinical Pathways and Flatiron Health, participants discussed how to develop and implement clinical pathways at cancer centers.

In this roundtable, part of a...

06/03/2024

Journal of Clinical Pathways

CBEx HIGHLIGHT

The Bear: Why Does Health Care Cost So Much? (Part 1)

06/03/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these entities contribute to...

In this Breaking Down Health...

06/03/2024

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

May/June 2024

Featured Article

Column

Current Issue

Special Reports

Subscribe

June 2024 Volume 10 Issue 3

Specialties

Events

Year Round Education

HMP Global Products